Glass House Brands Inc. (GLAS): Capital Expenditures

Annual figures by period end, from SEC filings.

$27.18M
Year ended 2025-12-31
-0.7%
3-year compound annual growth
+47.8%
5-year compound annual growth
$108.50M2020-12-31: $3.85M2021-12-31: $108.50M2022-12-31: $27.77M2023-12-31: $12.31M2024-12-31: $10.29M2025-12-31: $27.18M$27.18M
2020-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$27.18M+164.0%2026-03-24, From 2025-01-01
2024-12-31$10.29M-16.4%2026-03-24, From 2024-01-01
2023-12-31$12.31M-55.7%2025-03-25, From 2023-01-01
2022-12-31$27.77M-74.4%2024-04-02, From 2022-01-01
2021-12-31$108.50Mn/m2024-04-02, From 2021-01-01
2020-12-31$3.85Mn/a2022-04-01, From 2020-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Glass House Brands Inc. (GLAS)2025-12-31$27.18M+164.0%
biote Corp. (BTMD)2025-12-31$5.01M-22.0%
Marimed Inc. (MRMD)2025-12-31$1.17M-90.2%
Cronos Group Inc. (CRON)2025-12-31$25.72M+107.2%
Natural Alternatives International Inc (NAII)2026-06-30$3.70M+2.4%
Jushi Holdings Inc. (JUSH)2025-12-31$16.09M+241.8%
Mannatech Inc (MTEX)2025-12-31$1.35M+355.6%
Fitlife Brands, Inc. (FTLF)2025-12-31$42.0K+320.0%
Ascend Wellness Holdings, Inc. (AAWH)2025-12-31$26.01M+15.4%

Compare GLAS, BTMD, MRMD, CRON side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗